Biohaven CEO Vlad Coric finally had the attention of the FDA, and most importantly, Commissioner Marty Makary.
In late April, after the company’s spinocerebellar ataxia …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.









